Cyclana Bio

Cyclana Bio is a Cambridge-based biotechnology company pioneering tissue-level approaches to drug discovery. Founded in 2025 by Léa Wenger and Kevin Chalut, Cyclana Bio’s mission is to close the innovation gap in women’s health by discovering and developing treatments for endometriosis. The company’s platform integrates advanced tissue modeling with molecular and computational tools to reveal the mechanisms of disease and identify novel therapeutic targets.